⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for idasanutlin

Every month we try and update this database with for idasanutlin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study to Determine the Excretion Balance, Pharmacokinetics, Metabolism and Absolute Oral Bioavailability of a Single Oral Dose of [14C]-Labeled Idasanutlin and an Intravenous Tracer Dose of [13C]-Labeled Idasanutlin in a Single Cohort of Participants With Solid Tumors (Malignancies)NCT02828930
Solid Tumors
Idasanutlin
Placebo
[13C]-radiolabe...
[14C]-radiolabe...
18 Years - Hoffmann-La Roche
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)NCT02545283
Leukemia, Myelo...
Cytarabine
Idasanutlin
Placebo
18 Years - Hoffmann-La Roche
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid TumorsNCT04029688
Acute Myeloid L...
Acute Lymphobla...
Neuroblastoma
Solid Tumors
Idasanutlin
Venetoclax
Cyclophosphamid...
Topotecan
Fludarabine
Cytarabine
Intrathecal Che...
0 Years - 30 YearsHoffmann-La Roche
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)NCT03555149
Colorectal Canc...
Regorafenib
Atezolizumab
Imprime PGG
Bevacizumab
Isatuximab
Selicrelumab
Idasanutlin
AB928
LOAd703
18 Years - Hoffmann-La Roche
A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic TherapyNCT02670044
Leukemia, Myelo...
Cobimetinib
Idasanutlin
Venetoclax
18 Years - Hoffmann-La Roche
A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic TherapyNCT02670044
Leukemia, Myelo...
Cobimetinib
Idasanutlin
Venetoclax
18 Years - Hoffmann-La Roche
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaNCT02633059
Loss of Chromos...
Recurrent Plasm...
Dexamethasone
Idasanutlin
Ixazomib Citrat...
Laboratory Biom...
Pharmacological...
18 Years - Mayo Clinic
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)NCT03555149
Colorectal Canc...
Regorafenib
Atezolizumab
Imprime PGG
Bevacizumab
Isatuximab
Selicrelumab
Idasanutlin
AB928
LOAd703
18 Years - Hoffmann-La Roche
A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid TumorsNCT03362723
Solid Tumors
Idasanutlin
18 Years - Hoffmann-La Roche
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform StudyNCT04589845
Solid Tumors
Entrectinib
Entrectinib
Alectinib
Atezolizumab
Ipatasertib
Trastuzumab emt...
Idasanutlin
Inavolisib
Belvarafenib
Pralsetinib
GDC-6036
Camonsertib
- Hoffmann-La Roche
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia VeraNCT03287245
Polycythemia Ve...
Idasanutlin
18 Years - Hoffmann-La Roche
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaNCT02633059
Loss of Chromos...
Recurrent Plasm...
Dexamethasone
Idasanutlin
Ixazomib Citrat...
Laboratory Biom...
Pharmacological...
18 Years - Mayo Clinic
A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)NCT03135262
Follicular Lymp...
Lymphoma, Large...
Idasanutlin
Obinutuzumab
Venetoclax
Rituximab
18 Years - Hoffmann-La Roche
NCT Neuro Master Match - N²M² (NOA-20)NCT03158389
Glioblastoma, A...
APG101
Alectinib
Idasanutlin
Atezolizumab
Vismodegib
Temsirolimus
Palbociclib
18 Years - University Hospital Heidelberg
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform StudyNCT04589845
Solid Tumors
Entrectinib
Entrectinib
Alectinib
Atezolizumab
Ipatasertib
Trastuzumab emt...
Idasanutlin
Inavolisib
Belvarafenib
Pralsetinib
GDC-6036
Camonsertib
- Hoffmann-La Roche
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)NCT02545283
Leukemia, Myelo...
Cytarabine
Idasanutlin
Placebo
18 Years - Hoffmann-La Roche
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: